Nominations Now Open for the 2022 Cintas C.A.P.E. Awards, Honoring EVS Technicians

CINCINNATI–(BUSINESS WIRE)–To recognize and honor exceptional Environmental Services (EVS) technicians, Cintas Corporation (Nasdaq: CTAS) is accepting nominations for its 2022 C.A.P.E. Awards (Cleaning to Advance the Patient Experience) through August 8, 2022. The C.A.P.E. Awards celebrate EVS staff in acute or long-term care facilities who are at the frontline of patient care, providing clean and … [Read more…]

Artiva Biotherapeutics Celebrates Official Opening of San Diego Corporate Headquarters and R&D Lab Facilities

52,000-square-foot corporate headquarters in San Diego with R&D and GMP manufacturing center Builds on current capability at Artiva’s partner, GC Cell’s facility in Republic of Korea Custom-built GMP manufacturing center further enables Artiva’s leadership position in scaled, off-the-shelf NK and CAR-NK therapeutic manufacturing for treatment of solid and hematological cancers SAN DIEGO–(BUSINESS WIRE)–#CARNK—Artiva Biotherapeutics, Inc., … [Read more…]

BICMD Expands to Include All Major Medical Specialties

NEW YORK–(BUSINESS WIRE)–Best In Class MD (BICMD) announced its expansion of expert medical opinion (EMO) services to include 72 subspecialties within Internal Medicine, Surgery, Psychiatry, Radiology, Oncology and Obstetrics & Gynecology. This major initiative will double the company’s Expert Network by the end of 2022 to include over 350 fellowship-trained medical doctors. The strategic decision … [Read more…]

Ancestry® Reunites Family Torn Apart by Slavery Using Uncovered Letters in Powerful New Short Docu-Style Film, “A Dream Delivered: The Lost Letters of Hawkins Wilson”

black-ish and Law & Order actor Anthony Anderson hosts journey to bring together descendants of siblings separated during the mid-1800s LEHI, Utah–(BUSINESS WIRE)–Today, Ancestry®, the leader in family history, announced the premiere of a powerful new film – “A Dream Delivered: The Lost Letters of Hawkins Wilson” – which brings to light a family reunion … [Read more…]

Babylon Set to Join Russell 3000® Index

AUSTIN, Texas & LONDON–(BUSINESS WIRE)–Babylon (NYSE:BBLN) is set to join the broad-market Russell 3000® Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective after the US market opens on June 27, according to a preliminary list of additions posted June 3. Annual Russell indexes reconstitution captures the 4,000 largest US stocks as … [Read more…]

TROPION-Breast02 Phase 3 Trial of Datopotamab Deruxtecan Initiated in Patients with Previously Untreated Metastatic Triple Negative Breast Cancer

TOKYO & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo (TSE: 4568) today announced that the first patient was dosed in the global TROPION-Breast02 phase 3 trial evaluating the efficacy and safety of datopotamab deruxtecan (Dato-DXd) versus investigator’s choice of chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic triple negative breast cancer (TNBC) not eligible … [Read more…]

Evecxia Therapeutics Announces Leadership Transition to Support Next Phase of Development and Growth

Joseph M. Patti, Ph.D., Appointed President and CEO John J. Kaiser, Retires as CEO, Remains as Board Director RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Evecxia Therapeutics, a clinical stage biopharmaceutical company dedicated to realizing the therapeutic potential of serotonin synthesis amplification for the treatment of brain disorders, today announced that Joseph M. Patti, Ph.D., has been appointed … [Read more…]

Lumicell Appoints Brent Palmisano Chief Commercial Officer, Builds Commercial Team

Lauren Cohen Recently Joined as Vice President of Marketing and Communications NEWTON, Mass.–(BUSINESS WIRE)–, June 13, 2022 —Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced it is building a commercial team to prepare for market launch of the Lumicell Direct Visualization System (DVS), which includes its … [Read more…]

Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia A

Expanded relationship will build upon established processes initiated in 2019 to meet ASC Therapeutics clinical program WILMINGTON, Mass.–(BUSINESS WIRE)–$CRL #LIFEatCRL–Charles River Laboratories International, Inc. (NYSE: CRL) and ASC Therapeutics, a privately held biopharmaceutical company pioneering the development of transformative in vivo gene replacement, gene editing and allogeneic cell therapies, today announced they have agreed to … [Read more…]

LENSAR® Receives U.S. FDA Clearance of ALLY™ Adaptive Cataract Treatment System

ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its next-generation ALLY Adaptive Cataract Treatment System (“ALLY” or “ALLY System”). ALLY is the first FDA-cleared platform … [Read more…]